Ancora Pharmaceuticals

United States
Bellevue, Illinois, United States
7813053350 ★

Company profile

Ancora Pharmaceuticals company profile

Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.

Business identity

Contact email
[email protected]
Phone number
7813053350
Operating status
Closed
Company type
For Profit
Employee range
00051-00100 employees
Revenue range
$1K+
Founded
2001-01-01

Headquarters

Headquarters
Bellevue, Illinois, United States
Postal code
02155
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$800K
Last funding
Series Unknown / $800K / 2009-11-09
Last equity funding
Series Unknown / $800K
Investors
1
Founders
1
Articles
1
Exited on
2013-11-12

Founders and investors

Founders

Louis Schofield

Investors

University Growth Fund

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.